Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Etograb 600mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Medxone Healthcare

Salt Composition

Etodolac (600mg)

Overview Etograb 600mg Tablet ER

Arthrolief 600mg Extended-Release Tablets provide effective pain and inflammation relief. This medication is indicated for conditions such as rheumatoid arthritis, osteoarthritis, and acute pain episodes. Dosage and treatment duration should strictly adhere to your physician's instructions. Administering the tablet with food or milk minimizes potential gastrointestinal discomfort. Prior heart disease or stroke should be disclosed to your doctor before commencing treatment. Commonly reported side effects include nausea, vomiting, indigestion, and abdominal pain. Dizziness, somnolence, or visual abnormalities may also occur. For prolonged therapy, regular monitoring of kidney function, liver function, and blood counts is typically recommended by your healthcare provider. Protracted use carries the risk of serious complications, including peptic ulcers and renal impairment.

Primary Ingredients of Etograb 600mg Tablet ER

No text was provided to rewrite.

Uses of Etograb 600mg Tablet ER

Analgesia

Major Benefits of Etograb 600mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Etograb 600mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Etograb 600mg Tablet ER:

  • Vomiting
  • Stomach pain/epigastric pain
  • Nausea
  • Indigestion
  • Dizziness
  • Drowsiness

How to use Etograb 600mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Etograb 600mg Extended-Release Tablet with a meal.

How Etograb 600mg Tablet ER works:

Etograb 600mg Extended-Release tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated inflammation, such as redness and edema.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Etograb 600mg Extended-Release Tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Etograb 600mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Etograb 600mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Etograb 600mg Extended-Release tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

The extended-release Etograb 600mg tablet is likely safe for individuals with impaired kidney function. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Etograb 600mg extended-release tablets in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Etograb 600mg Tablet ER :

Should you forget a dose of Etograb 600mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Etograb 600mg Tablet ER

LabelValue
Chemical Type Indole Carboxylic Acid Derivatives
Developing Habits No.
Type of Therapy Pain Relievers

FAQs on Etograb 600mg Tablet ER

Etograb 600mg Extended-Release Tablets are not narcotics; they're non-steroidal anti-inflammatory drugs (NSAIDs).
Etograb 600mg Extended-Release tablets are not intoxicating and do not pose a risk of abuse or dependence. Consult your doctor if you experience any adverse effects.
Etograb 600mg Tablet ER should not be used by patients allergic to it or its ingredients. If you have any allergy concerns or are a first-time user, consult your doctor.
Etograb 600mg Tablet ER, when used long-term or at high doses, can cause renal issues, including proteinuria, hematuria, and dysuria. Patients with a history of, or existing, heart failure, impaired kidney function, or hypertension are at increased risk. This risk is also elevated in patients taking diuretics or other nephrotoxic medications, as well as those over 65 or experiencing dehydration. Therefore, kidney function monitoring is advised for these individuals.
Etograb 600mg Extended-Release Tablets may cause drowsiness, dizziness, fatigue, and visual disturbances, though these side effects are uncommon. Avoid driving or operating machinery if you experience them.
For effective treatment, take Etograb 600mg Extended-Release tablets as prescribed by your doctor. Continue taking the medication for the full course, even if you feel better; stopping early may cause symptoms to recur or intensify.
Etograb 600mg Tablet ER
131
MRP 160
18% off